The focus of this webinar is on Parkinson’s Disease – using the Lessons Learned to overcome the challenges as cell based therapies move from discovery to the clinic.
This webinar will address questions regarding the two RFAs establishing the Alpha Stem Cell Clinic Network. RFA 13-06 is the Alpha Clinic award and RFA 13-07 is the Coordinating and Information Management Center.
The 19th annual BIO-Europe® event will be the largest biotechnology partnering conference held in Europe. Over 3,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships.
Curt I. Civin, M.D., Associate Dean for Research & Director of the Center for Stem Cell Biology & Regenerative Medicine at The University of Maryland School of Medicine invites you to An Evening of Hope: A Benefit for Stem Cell Research including a reception, dinner and program with special guests.
BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships.
Register and submit your abstract today for MSC 2013: Adult Stem Cell Therapy and Regenerative Medicine! MSC 2013, which will take place in Cleveland, OH, August 19-21, 2013, will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine.
The TEBC aims to accelerate the commercialization of tissue engineered and biomaterial-based regenerative medicine products by identifying the unique requirements facing this subgroup of the field.
This invitation-only event is an intimate and informal afternoon featuring rapid-fire pitches by the RM industry’s cutting-edge, early-stage companies, a panel of leading venture capitalists with interest in the space and a talk by one of the field’s top researchers.